Biomedical Engineering Seminar

October 22, 2018
October 22, 2018
Speaker: Yusef Khan, Ph.D.
                University of Connecticut    
Title: Regenerative Engineering-based Strategies for Bone Repair   
Location: Biomedical Engineering, Room 102
Time: 1:45 p.m. to 2:45 p.m.

Dr. Yusuf Khan received his bachelor’s degree from Boston University in 1990, and master’s and doctorate degrees in Biomedical Engineering from Drexel University in Philadelphia in 1999 and 2005, respectively. His expertise is in the area of orthopaedic biomaterials, musculoskeletal tissue regeneration and regenerative engineering.  His specific research interests are in the area of biodegradable polymer/ceramic composites for bone repair, low intensity ultrasound as a tool to enhance tissue-engineering-based tissue repair, and growth factor delivery.  He is the co-author of 45 peer-reviewed journal articles and 11 book chapters, and is co-editor of two books, and several granted and pending patent applications.

Dr. Khan has served on the faculties of the University of Virginia (2005-2008) and the University of Connecticut (2008-present), where he is currently in the Department of Orthopaedic Surgery, Department of Biomedical Engineering, and the Department of Materials Science & Engineering. He was recently promoted to the rank of Associate Professor in the Department of Orthopaedic Surgery.  He has been course director and lecturer in the introductory course in Biomaterials for the past 8 years and the course in Tissue Engineering for the past 5 years, both within the department of Biomedical Engineering.

Dr. Khan has been active in the Society for Biomaterials for over a decade and has served as Chair, Vice Chair, and Program Chair of the Orthopaedic Biomaterials Special Interest Group and Vice Chair of the Biomaterials Education Special Interest Group.  Dr. Khan also served as the Secretary for the Tissue Engineered Medical Products section of ASTM.  Dr. Khan was also a committee member of the National Academy of Medicine’s Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process and is a co-author of the publication that arose from that committee in 2011.  He also serves on the editorial board of the Journal of Biomedical Materials Research (part A).

For more information, please contact Robin Yarborough at 848-445-6872 or at